|
1
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Calligari P, Bobone S, Ricci G and Bocedi
A: Molecular investigation of SARS-CoV-2 proteins and their
interactions with antiviral drugs. Viruses. 12(445)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu J, Zheng X, Tong Q, Li W, Wang B,
Sutter K, Trilling M, Lu M, Dittmer U and Yang D: Overlapping and
discrete aspects of the pathology and pathogenesis of the emerging
human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J
Med Virol. 92:491–494. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from
patients with pneumonia in China, 2019. N Engl J Med. 382:727–733.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chu H, Chan JF, Wang Y, Yuen TT, Chai Y,
Hou Y, Shuai H, Yang D, Hu B, Huang X, et al: Comparative
replication and immune activation profiles of SARS-CoV-2 and
SARS-CoV in human lungs: An ex vivo study with implications for the
pathogenesis of COVID-19. Clin Infect Dis. 71:1400–1409.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ammad Ud Din M and Boppana LK: An update
on the 2019-nCoV outbreak. Am J Infect Control.
48(713)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
National Health Commission of the People's
Republic of China. urihttp://www.nhc.gov.cn/simplehttp://www.nhc.gov.cn/.
Accessed November, 2020.
|
|
8
|
Johns Hopkins University and Medicine.
urihttps://coronavirus.jhu.edu/map.htmlsimplehttps://coronavirus.jhu.edu/map.html.
Accessed November, 2020.
|
|
9
|
Bulut C and Kato Y: Epidemiology of
COVID-19. Turk J Med Sci. 50:563–570. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cai H: Sex difference and smoking
predisposition in patients with COVID-19. Lancet Respir Med.
8(e20)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gebhard C, Regitz-Zagrosek V, Neuhauser
HK, Morgan R and Klein SL: Impact of sex and gender on COVID-19
outcomes in Europe. Biol Sex Differ. 11(29)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
La Vignera S, Cannarella R, Condorelli RA,
Torre F, Aversa A and Calogero AE: Sex-specific SARS-CoV-2
mortality: Among hormone-modulated ACE2 expression, risk of venous
thromboembolism and hypovitaminosis D. Int J Mol Sci.
21(2948)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang Y, Wang Y, Chen Y and Qin Q: Unique
epidemiological and clinical features of the emerging 2019 novel
coronavirus pneumonia (COVID-19) implicate special control
measures. J Med Virol. 92:568–576. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Benvenuto D, Giovanetti M, Ciccozzi A,
Spoto S, Angeletti S and Ciccozzi M: The 2019-new coronavirus
epidemic: Evidence for virus evolution. J Med Virol. 92:455–459.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Salata C, Calistri A, Parolin C and Palu
G: Coronaviruses: A paradigm of new emerging zoonotic diseases.
Pathog Dis. 77(ftaa006)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen J: Pathogenicity and transmissibility
of 2019-nCoV-A quick overview and comparison with other emerging
viruses. Microbes Infect. 22:69–71. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang W, Du RH, Li B, Zheng XS, Yang XL,
Hu B, Wang YY, Xiao GF, Yan B, Shi ZL and Zhou P: Molecular and
serological investigation of 2019-nCoV infected patients:
Implication of multiple shedding routes. Emerg Microbes Infect.
9:386–389. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ceraolo C and Giorgi FM: Genomic variance
of the 2019-nCoV coronavirus. J Med Virol. 92:522–528.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Baruah V and Bose S:
Immunoinformatics-aided identification of T cell and B cell
epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol.
92:495–500. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Morse JS, Lalonde T, Xu S and Liu WR:
Learning from the Past: Possible urgent prevention and treatment
options for severe acute respiratory infections caused by
2019-nCoV. Chembiochem. 21:730–738. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kannan S, Shaik Syed Ali P, Sheeza A and
Hemalatha K: COVID-19 (Novel Coronavirus 2019)-recent trends. Eur
Rev Med Pharmacol Sci. 24:2006–2011. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Vankadari N and Wilce JA: Emerging WuHan
(COVID-19) coronavirus: Glycan shield and structure prediction of
spike glycoprotein and its interaction with human CD26. Emerg
Microbes Infect. 9:601–604. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kumar S, Maurya VK, Prasad AK, Bhatt MLB
and Saxena SK: Structural, glycosylation and antigenic variation
between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus
(SARS-CoV). Virusdisease. 31:13–21. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H,
Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and
epidemiology of 2019 novel coronavirus: Implications for virus
origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu Y, Yang Y, Zhang C, Huang F, Wang F,
Yuan J, Wang Z, Li J, Li J, Feng C, et al: Clinical and biochemical
indexes from 2019-nCoV infected patients linked to viral loads and
lung injury. Sci China Life Sci. 63:364–374. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang K, Chen W, Zhou YS, Lian JQ, Zhang Z,
Du P, Gong L, Zhang Y, Cui HY, Geng JJ, et al: SARS-CoV-2 invades
host cells via a novel route: CD147-spike protein. bioRxiv: Mar 14,
2020 (Epub ahead of print). doi: urihttps://doi.org/10.1101/2020.03.14.988345simplehttps://doi.org/10.1101/2020.03.14.988345.
|
|
27
|
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu
SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al: A pathological report
of three COVID-19 cases by minimally invasive autopsies. Zhonghua
Bing Li Xue Za Zhi. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
28
|
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y and
Zuo W: Single-cell RNA expression profiling of ACE2, the putative
receptor of Wuhan 2019-nCoV. bioRxiv: Jan 26, 2020 (Epub ahead of
print). doi: urihttps://doi.org/10.1101/2020.01.26.919985simplehttps://doi.org/10.1101/2020.01.26.919985.
|
|
29
|
Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan
Y, Zhou L, Liu Z, Ren Y, Yuan L, et al: Aveolar macrophage
activation and cytokine storm in the pathogenesis of severe
COVID-19. Res Square: Mar 25, 2020 (Epub ahead of print). doi:
urihttps://doi.org/10.21203/rs.3.rs-19346/v1simplehttps://doi.org/10.21203/rs.3.rs-19346/v1.
|
|
30
|
Angel-Korman A, Brosh T, Glick K and Leiba
A: COVID-19, the kidney and hypertension. Harefuah. 159:231–234.
2020.PubMed/NCBI
|
|
31
|
Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A,
Zhou J, Shi G, Fang N, Fan J, et al: Specific ACE2 expression in
cholangiocytes may cause liver damage after 2019-nCoV infection.
bioRxiv: Feb 4, 2020 (Epub ahead of print). doi:
10.1101/2020.02.03.931766.
|
|
32
|
Guan GW, Gao L, Wang JW, Wen XJ, Mao TH,
Peng SW, Zhang T, Chen XM and Lu FM: Exploring the mechanism of
liver enzyme abnormalities in patients with novel
coronavirus-infected pneumonia. Zhonghua Gan Zang Bing Za Zhi.
28:100–106. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
33
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo
Q, Ji R, Wang H, Wang Y and Zhou Y: Prevalence of comorbidities in
the novel Wuhan coronavirus (COVID-19) infection: A systematic
review and meta-analysis. Int J Infect Dis. 94:91–95.
2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu
L, Bi Z and Zhao Y: Prevalence and impact of cardiovascular
metabolic diseases on COVID-19 in China. Clin Res Cardiol.
109:531–538. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang W, Tang J and Wei F: Updated
understanding of the outbreak of 2019 novel coronavirus (2019-nCoV)
in Wuhan, China. J Med Virol. 92:441–447. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q,
Chang J, Hong C, Zhou Y, Wang D, et al: Neurologic manifestations
of hospitalized patients with coronavirus disease 2019 in Wuhan,
China. JAMA Neurol. 77:683–690. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Feng G, Zheng KI, Yan QQ, Rios RS, Targher
G, Byrne CD, Poucke SV, Liu WY and Zheng MH: COVID-19 and liver
dysfunction: Current insights and emergent therapeutic strategies.
J Clin Transl Hepatol. 8:18–24. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen L, Liu M, Zhang Z, Qiao K, Huang T,
Chen M, Xin N, Huang Z, Liu L, Zhang G and Wang J: Ocular
manifestations of a hospitalised patient with confirmed 2019 novel
coronavirus disease. Br J Ophthalmol. 104:748–751. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hedou M, Carsuzaa F, Chary E, Hainaut E,
Cazenave-Roblot F and Masson Regnault M: Comment on ‘Cutaneous
manifestations in COVID-19: A first perspective’ by Recalcati S. J
Eur Acad Dermatol Venereol. 34:e299–e300. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Cui S, Chen S, Li X, Liu S and Wang F:
Prevalence of venous thromboembolism in patients with severe novel
coronavirus pneumonia. J Thromb Haemost. 18:1421–1424.
2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Singhal T: A review of coronavirus
disease-2019 (COVID-19). Indian J Pediatr. 87:281–286.
2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chen L, Liu HG, Liu W, Liu J, Liu K, Shang
J, Deng Y and Wei S: Analysis of clinical features of 29 patients
with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za
Zhi. 43:203–208. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
44
|
Jin Y, Wang M, Zuo Z, Fan C, Ye F, Cai Z,
Wang Y, Cui H, Pan K and Xu A: Diagnostic value and dynamic
variance of serum antibody in coronavirus disease 2019. Int J
Infect Dis. 94:49–52. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tobin MJ: Basing respiratory management of
COVID-19 on physiological principles. Am J Respir Crit Care Med.
201:1319–1320. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ganji A, Farahani I, Khansarinejad B,
Ghazavi A and Mosayebi G: Increased expression of CD8 marker on
T-cells in COVID-19 patients. Blood Cells Mol Dis.
83(102437)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chu DKW, Pan Y, Cheng SMS, Hui KPY,
Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, et al:
Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an
outbreak of pneumonia. Clin Chem. 66:549–555. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai
X, Li L, He R, Tan Y, Deng X, et al: Detectable 2019-nCoV viral RNA
in blood is a strong indicator for the further clinical severity.
Emerg Microbes Infect. 9:469–473. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z,
Huang Z, Li X, Deng K, Lin B and Gao Z: SARS-CoV-2 can be detected
in urine, blood, anal swabs, and oropharyngeal swabs specimens. J
Med Virol, Apr 24, 2020 (Online ahead of print).
|
|
50
|
Corman VM, Landt O, Kaiser M, Molenkamp R,
Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML,
et al: Detection of 2019 novel coronavirus (2019-nCoV) by real-time
RT-PCR. Euro Surveill. 25(2000045)2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Chan JF, Yip CC, To KK, Tang TH, Wong SC,
Leung KH, Fung AY, Ng AC, Zou Z, Tsoi HW, et al: Improved molecular
diagnosis of COVID-19 by the novel, highly sensitive and specific
COVID-19-RdRp/Hel Real-time reverse transcription-PCR assay
validated in vitro and with clinical specimens. J Clin Microbiol.
58:e00310–20. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ferrari D, Motta A, Strollo M, Banfi G and
Locatelli M: Routine blood tests as a potential diagnostic tool for
COVID-19. Clin Chem Lab Med. 58:1095–1099. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tian S, Hu W, Niu L, Liu H, Xu H and Xiao
SY: Pulmonary pathology of early-phase 2019 novel coronavirus
(COVID-19) pneumonia in two patients with lung cancer. J Thorac
Oncol. 15:700–704. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu
SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al: A pathological report
of three COVID-19 cases by minimal invasive autopsies. Zhonghua
Bing Li Xue Za Zhi. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
55
|
Li H, Wang YM, Xu JY and Cao B: Potential
antiviral therapeutics for 2019 novel coronavirus. Zhonghua Jie He
He Hu Xi Za Zhi. 43:170–172. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
56
|
Liu X, Li Z, Liu S, Sun J, Chen Z, Jiang
M, Zhang Q, Wei Y, Wang X, Huang YY, et al: Potential therapeutic
effects of dipyridamole in the severely ill patients with COVID-19.
Acta Pharm Sin B. 10:1205–1215. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Grant WB, Lahore H, McDonnell SL, Baggerly
CA, French CB, Aliano JL and Bhattoa HP: Evidence that vitamin D
supplementation could reduce risk of influenza and COVID-19
infections and deaths. Nutrients. 12(988)2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Fan HH, Wang LQ, Liu WL, An XP, Liu ZD, He
XQ, Song LH and Tong YG: Repurposing of clinically approved drugs
for treatment of coronavirus disease 2019 in a 2019-novel
coronavirus-related coronavirus model. Chin Med J (Engl).
133:1051–1056. 2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Joshi RS, Jagdale SS, Bansode SB, Shankar
SS, Tellis MB, Pandya VK, Chugh A, Giri AP and Kulkarni MJ:
Discovery of potential multi-target-directed ligands by targeting
host-specific SARS-CoV-2 structurally conserved main protease. J
Biomol Struct Dyn: May 5, 2020 (Epub ahead of print). doi:
10.1080/07391102.2020.1760137.
|
|
60
|
Serseg T, Benarous K and Yousfi M:
Hispidin and Lepidine E: Two natural compounds and folic acid as
potential inhibitors of 2019-novel coronavirus main protease
(2019-nCoVMpro), molecular docking and SAR study. Curr Comput Aided
Drug Des: Apr 21, 2020 (Epub ahead of print).
|
|
61
|
Abena PM, Decloedt EH, Bottieau E, Suleman
F, Adejumo P, Sam-Agudu NA, Muyembe TamFum JJ, Seydi M, Eholie SP,
Mills EJ, et al: Chloroquine and hydroxychloroquine for the
prevention or treatment of COVID-19 in Africa: Caution for
inappropriate off-label use in healthcare settings. Am J Trop Med
Hyg. 102:1184–1188. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Tufan A, Avanoğlu Güler A and
Matucci-Cerinic M: COVID-19, immune system response,
hyperinflammation and repurposing antirheumatic drugs. Turk J Med
Sci. 50:620–632. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Shetty AK: Mesenchymal stem cell infusion
shows promise for combating coronavirus (COVID-19)-induced
pneumonia. Aging Dis. 11:462–464. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Sun ML, Yang JM, Sun YP and Su GH:
Inhibitors of RAS might be a good choice for the therapy of
COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:219–222.
2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
65
|
Kong LM, Liao CG, Zhang Y, Xu J, Li Y,
Huang W, Zhang Y, Bian H and Chen ZN: A regulatory loop involving
miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer
invasion and metastasis. Cancer Res. 74:3764–3778. 2014.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Qin YY, Zhou YH, Lu YQ, Sun F, Yang S,
Harypursat V and Chen YK: Effectiveness of glucocorticoid therapy
in patients with severe coronavirus disease 2019: Protocol of a
randomized controlled trial. Chin Med J (Engl). 133:1080–1086.
2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Choudhury R, Barrett CD, Moore HB, Moore
EE, McIntyre RC, Moore PK, Talmor DS, Nydam TL and Yaffe MB:
Salvage use of tissue plasminogen activator (tPA) in the setting of
acute respiratory distress syndrome (ARDS) due to COVID-19 in the
USA: A Markov decision analysis. World J Emerg Surg.
15(29)2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Taniguchi H, Ogawa F, Honzawa H, Yamaguchi
K, Niida S, Shinohara M, Takahashi K, Iwashita M, Abe T, Kubo S, et
al: Veno-venous extracorporeal membrane oxygenation for severe
pneumonia: COVID-19 case in Japan. Acute Med Surg.
7(e509)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Omolo CA, Soni N, Fasiku VO, Mackraj I and
Govender T: Update on therapeutic approaches and emerging therapies
for SARS-CoV-2 virus. Eur J Pharmacol. 883(173348)2020.PubMed/NCBI View Article : Google Scholar
|
